Table 2 Pathological characteristics of surgical patients ( n = 41)*
No. (%) | ||
|---|---|---|
Gleason score † | 6 | 3 (7.7) |
7 | 23 (59.0) | |
8 | 9 (23.1) | |
9 | 4 (10.3) | |
Gleason pattern † | 3 + 3 | 2 (5.1) |
3 + 4 | 8 (20.5) | |
3 + 5 | 1 (2.6) | |
4 + 3 | 16 (41.0) | |
4 + 4 | 8 (20.5) | |
4 + 5 | 3 (7.7) | |
5 + 4 | 1 (2.6) | |
Pathological T stage ‡ | pT2a | 1 (2.4) |
pT2b | 3 (7.3) | |
pT2c | 15 (36.6) | |
pT3a | 9 (22) | |
pT3b | 10 (24.4) | |
pT4a | 1 (2.4) | |
pT4b | 0 (0.0) | |
pTx | 2 (4.9) | |
Margins | Negative | 23 (59.0) |
Positive | 16 (41.0) | |
Extracapsular extension | No | 21 (53.8) |
Yes | 18 (46.2) | |
SV invasion | No | 28 (71.8) |
Yes | 11 (28.2) | |
Perineural invasion | No | 5 (12.8) |
Yes | 19 (48.7) | |
n/a | 15 (38.5) | |
Intraprostatic cancer extent (Mean % (SD)) | - | 27.3 (22.9) |
Pathological N stage ‡ | pN0 | 30 (73.2) |
pN1 | 11 (26.8) | |
Number of LN (Mean (SD)) | - | 17.6 (7.3) |
LN density (Mean (SD)) | - | 3.6 (8.3) |